NFIX_HUMAN - dbPTM
NFIX_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NFIX_HUMAN
UniProt AC Q14938
Protein Name Nuclear factor 1 X-type
Gene Name NFIX
Organism Homo sapiens (Human).
Sequence Length 502
Subcellular Localization Nucleus.
Protein Description Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication..
Protein Sequence MYSPYCLTQDEFHPFIEALLPHVRAFSYTWFNLQARKRKYFKKHEKRMSKDEERAVKDELLGEKPEIKQKWASRLLAKLRKDIRPEFREDFVLTITGKKPPCCVLSNPDQKGKIRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERLYKSPQCSNPGLCVQPHHIGVTIKELDLYLAYFVHTPESGQSDSSNQQGDADIKPLPNGHLSFQDCFVTSGVWNVTELVRVSQTPVATASGPNFSLADLESPSYYNINQVTLGRRSITSPPSTSTTKRPKSIDDSEMESPVDDVFYPGTGRSPAAGSSQSSGWPNDVDAGPASLKKSGKLDFCSALSSQGSSPRMAFTHHPLPVLAGVRPGSPRATASALHFPSTSIIQQSSPYFTHPTIRYHHHHGQDSLKEFVQFVCSDGSGQATGQPNGSGQGKVPGSFLLPPPPPVARPVPLPMPDSKSTSTAPDGAALTPPSPSFATTGASSANRFVSIGPRDGNFLNIPQQSQSWFL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MYSPYCLTQ
------CCCCCCCCC
20.5323663014
3 (in isoform 3)Phosphorylation-14.2224719451
3Phosphorylation-----MYSPYCLTQD
-----CCCCCCCCCC
14.2223663014
5Phosphorylation---MYSPYCLTQDEF
---CCCCCCCCCCCH
8.3123663014
8PhosphorylationMYSPYCLTQDEFHPF
CCCCCCCCCCCHHHH
30.3423663014
40PhosphorylationLQARKRKYFKKHEKR
HHHHHHHHHHHHHHH
25.3522817900
49PhosphorylationKKHEKRMSKDEERAV
HHHHHHCCHHHHHHH
40.7720068231
64UbiquitinationKDELLGEKPEIKQKW
HHHHCCCCHHHHHHH
46.26-
145PhosphorylationKGIPLESTDGERLYK
CCCCCCCCCCCHHCC
38.35-
231PhosphorylationVTELVRVSQTPVATA
HHHEEEEECCCEEEC
20.1322199227
233 (in isoform 3)Phosphorylation-16.5424719451
233PhosphorylationELVRVSQTPVATASG
HEEEEECCCEEECCC
16.5422199227
237PhosphorylationVSQTPVATASGPNFS
EECCCEEECCCCCCC
22.9122199227
239PhosphorylationQTPVATASGPNFSLA
CCCEEECCCCCCCHH
50.8928348404
244 (in isoform 3)Phosphorylation-29.3224719451
244PhosphorylationTASGPNFSLADLESP
ECCCCCCCHHHCCCC
29.3222199227
250PhosphorylationFSLADLESPSYYNIN
CCHHHCCCCCCEECC
26.8321712546
250 (in isoform 3)Phosphorylation-26.8324719451
252PhosphorylationLADLESPSYYNINQV
HHHCCCCCCEECCEE
49.9122199227
253PhosphorylationADLESPSYYNINQVT
HHCCCCCCEECCEEE
12.1517360941
254PhosphorylationDLESPSYYNINQVTL
HCCCCCCEECCEEEE
17.5722199227
265 (in isoform 3)Phosphorylation-28.9424719451
265PhosphorylationQVTLGRRSITSPPST
EEEECCCCCCCCCCC
28.9423401153
267PhosphorylationTLGRRSITSPPSTST
EECCCCCCCCCCCCC
36.1130266825
268 (in isoform 3)Phosphorylation-32.8924719451
268PhosphorylationLGRRSITSPPSTSTT
ECCCCCCCCCCCCCC
32.8929255136
271 (in isoform 3)Phosphorylation-38.0724719451
271PhosphorylationRSITSPPSTSTTKRP
CCCCCCCCCCCCCCC
38.0730266825
272PhosphorylationSITSPPSTSTTKRPK
CCCCCCCCCCCCCCC
35.5530266825
273PhosphorylationITSPPSTSTTKRPKS
CCCCCCCCCCCCCCC
38.1223403867
274PhosphorylationTSPPSTSTTKRPKSI
CCCCCCCCCCCCCCC
36.1023403867
275PhosphorylationSPPSTSTTKRPKSID
CCCCCCCCCCCCCCC
25.4823403867
279SumoylationTSTTKRPKSIDDSEM
CCCCCCCCCCCHHHC
65.1728112733
280PhosphorylationSTTKRPKSIDDSEME
CCCCCCCCCCHHHCC
33.6522167270
280 (in isoform 3)Phosphorylation-33.6524719451
284PhosphorylationRPKSIDDSEMESPVD
CCCCCCHHHCCCCCC
34.7923401153
284 (in isoform 3)Phosphorylation-34.7924719451
288 (in isoform 3)Phosphorylation-28.9824719451
288PhosphorylationIDDSEMESPVDDVFY
CCHHHCCCCCCCCCC
28.9830266825
295PhosphorylationSPVDDVFYPGTGRSP
CCCCCCCCCCCCCCC
10.7030266825
298PhosphorylationDDVFYPGTGRSPAAG
CCCCCCCCCCCCCCC
25.5623927012
301 (in isoform 3)Phosphorylation-21.8924719451
301PhosphorylationFYPGTGRSPAAGSSQ
CCCCCCCCCCCCCCC
21.8923401153
306PhosphorylationGRSPAAGSSQSSGWP
CCCCCCCCCCCCCCC
22.0723927012
307 (in isoform 2)Phosphorylation-32.9122210691
307 (in isoform 3)Phosphorylation-32.9124719451
307PhosphorylationRSPAAGSSQSSGWPN
CCCCCCCCCCCCCCC
32.9123927012
309PhosphorylationPAAGSSQSSGWPNDV
CCCCCCCCCCCCCCC
32.5323927012
310PhosphorylationAAGSSQSSGWPNDVD
CCCCCCCCCCCCCCC
36.9223927012
322PhosphorylationDVDAGPASLKKSGKL
CCCCCCCHHHCCCCC
43.8023927012
326PhosphorylationGPASLKKSGKLDFCS
CCCHHHCCCCCCHHH
39.3030576142
336PhosphorylationLDFCSALSSQGSSPR
CCHHHHHHCCCCCCC
21.9721712546
337PhosphorylationDFCSALSSQGSSPRM
CHHHHHHCCCCCCCE
39.1419690332
340PhosphorylationSALSSQGSSPRMAFT
HHHHCCCCCCCEEEC
29.5429743597
341 (in isoform 3)Phosphorylation-24.2924719451
341PhosphorylationALSSQGSSPRMAFTH
HHHCCCCCCCEEECC
24.2929255136
343Asymmetric dimethylarginineSSQGSSPRMAFTHHP
HCCCCCCCEEECCCC
30.89-
343MethylationSSQGSSPRMAFTHHP
HCCCCCCCEEECCCC
30.89-
347PhosphorylationSSPRMAFTHHPLPVL
CCCCEEECCCCCCEE
15.1023927012
361PhosphorylationLAGVRPGSPRATASA
EECCCCCCCCCCHHH
17.5629255136
361 (in isoform 3)Phosphorylation-17.5624719451
365PhosphorylationRPGSPRATASALHFP
CCCCCCCCHHHCCCC
23.5622199227
367PhosphorylationGSPRATASALHFPST
CCCCCCHHHCCCCCC
27.3222199227
373PhosphorylationASALHFPSTSIIQQS
HHHCCCCCCCHHCCC
33.5728857561
374PhosphorylationSALHFPSTSIIQQSS
HHCCCCCCCHHCCCC
24.9624719451
374 (in isoform 3)Phosphorylation-24.9624719451
375PhosphorylationALHFPSTSIIQQSSP
HCCCCCCCHHCCCCC
23.2528857561
380PhosphorylationSTSIIQQSSPYFTHP
CCCHHCCCCCCCCCC
19.5322199227
380 (in isoform 3)Phosphorylation-19.5324719451
381PhosphorylationTSIIQQSSPYFTHPT
CCHHCCCCCCCCCCC
21.2022199227
383PhosphorylationIIQQSSPYFTHPTIR
HHCCCCCCCCCCCEE
24.0622199227
385PhosphorylationQQSSPYFTHPTIRYH
CCCCCCCCCCCEECC
22.5422199227
388PhosphorylationSPYFTHPTIRYHHHH
CCCCCCCCEECCCCC
15.52-
390MethylationYFTHPTIRYHHHHGQ
CCCCCCEECCCCCCC
27.49-
390Asymmetric dimethylarginineYFTHPTIRYHHHHGQ
CCCCCCEECCCCCCC
27.49-
399PhosphorylationHHHHGQDSLKEFVQF
CCCCCCCCHHHHHHH
33.1928348404
401 (in isoform 6)Phosphorylation-53.7228348404
404 (in isoform 6)Phosphorylation-4.5328348404
408 (in isoform 6)Phosphorylation-3.0328348404
408 (in isoform 5)Phosphorylation-3.0328348404
409 (in isoform 3)Phosphorylation-39.4428348404
411 (in isoform 5)Phosphorylation-19.8528348404
412 (in isoform 6)Phosphorylation-32.4928348404
412 (in isoform 3)Phosphorylation-32.4928348404
415 (in isoform 5)Phosphorylation-19.7528348404
416 (in isoform 3)Phosphorylation-28.5828348404
419 (in isoform 5)Phosphorylation-48.7928348404
420 (in isoform 3)Phosphorylation-49.7528348404
424 (in isoform 6)Phosphorylation-50.6724719451
426 (in isoform 6)Phosphorylation-37.0528348404
431 (in isoform 5)Phosphorylation-11.4224719451
432 (in isoform 6)Phosphorylation-8.2124719451
432 (in isoform 3)Phosphorylation-8.2124719451
433 (in isoform 5)Phosphorylation-5.8828348404
434 (in isoform 3)Phosphorylation-41.3128348404
439 (in isoform 5)Phosphorylation-9.7124719451
440 (in isoform 3)Phosphorylation-18.8124719451
463PhosphorylationAPDGAALTPPSPSFA
CCCCCCCCCCCCCCC
28.5527251275
466PhosphorylationGAALTPPSPSFATTG
CCCCCCCCCCCCCCC
34.0927251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NFIX_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NFIX_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NFIX_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HDAC1_HUMANHDAC1physical
11896613
RB_HUMANRB1physical
11896613
SKI_HUMANSKIgenetic
9380514
PIR_HUMANPIRphysical
9079676
JMJD6_HUMANJMJD6physical
23455924
NFIX_HUMANNFIXphysical
25416956
QRIC1_HUMANQRICH1physical
25416956
ZN614_HUMANZNF614physical
25416956

Drug and Disease Associations
Kegg Disease
OMIM Disease
614753Sotos syndrome 2 (SOTOS2)
602535Marshall-Smith syndrome (MRSHSS)
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NFIX_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY.

TOP